ReviewBiologics : targets & therapy2018

Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent

Bhagyashri D Navalkele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.